Skip to content

PDS Biotechnology Corp: filings

Every PDS Biotechnology Corp annual and quarterly report in the SEC record with the published financial measures it tagged, 44 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-13fiscal Q2 2026351030001140361-26-032824
10-Q2026-05-14fiscal Q1 202635730001140361-26-021286
10-K2026-03-30fiscal FY 202541980001140361-26-012030
10-Q2025-11-13fiscal Q3 2025371110001140361-25-041976
10-Q2025-08-13fiscal Q2 2025371070001140361-25-030825
10-Q2025-05-14fiscal Q1 202535740001140361-25-018967
10-K2025-03-27fiscal FY 202442980001140361-25-010717
10-Q2024-11-14fiscal Q3 2024401160001140361-24-046891
10-Q2024-08-13fiscal Q2 2024401130001140361-24-037067
10-Q2024-05-15fiscal Q1 202436740001140361-24-026295
10-K2024-03-28fiscal FY 202340960001140361-24-016265
10-Q2023-11-14fiscal Q3 2023381150001140361-23-053242
10-Q2023-08-14fiscal Q2 2023381120001140361-23-039544
10-Q2023-05-15fiscal Q1 202336770001140361-23-024692
10-K2023-03-28fiscal FY 202240980001140361-23-014279
10-Q2022-11-14fiscal Q3 2022371120001140361-22-041370
10-Q2022-08-08fiscal Q2 2022361050001140361-22-028567
10-Q2022-05-11fiscal Q1 202235740001140361-22-018571
10-K2022-03-31fiscal FY 202138820001140361-22-012244
10-Q2021-11-10fiscal Q3 2021361060001140361-21-037345
10-Q2021-08-12fiscal Q2 2021361060001140361-21-028002
10-Q2021-05-13fiscal Q1 202135740001140361-21-017113
10-K2021-03-18fiscal FY 202037820001140361-21-009142
10-Q2020-11-13fiscal Q3 202034890001140361-20-025429
10-Q2020-08-13fiscal Q2 202036970001140361-20-018339
10-Q2020-05-13fiscal Q1 202036720001140361-20-011497
10-K2020-03-27fiscal FY 201941840001140361-20-007252
10-Q2019-11-07fiscal Q3 201935910001140361-19-019968
10-Q2019-08-01fiscal Q2 201937960001140361-19-013922
10-Q2019-05-14fiscal Q1 201937740001140361-19-009128
10-K2019-02-21fiscal FY 201832660001140361-19-003636
10-Q2018-11-01fiscal Q3 201829740001140361-18-042020
10-Q2018-08-01fiscal Q2 201828700001140361-18-034641
10-Q2018-05-01fiscal Q1 201828580001140361-18-020718
10-K2018-03-01fiscal FY 2017331270001140361-18-011218
10-Q2017-11-01fiscal Q3 201728720001140361-17-040539
10-Q2017-08-01fiscal Q2 201728720001140361-17-029588
10-Q2017-05-03fiscal Q1 201724500001140361-17-018095
10-K2017-03-02fiscal FY 2016281130001140361-17-010287
10-Q2016-11-01fiscal Q3 201625670001140361-16-084377
10-Q2016-08-03fiscal Q2 201625650001140361-16-074623
10-Q2016-05-03fiscal Q1 201625510001140361-16-063034
10-K2016-03-08fiscal FY 2015291140001140361-16-056994
10-Q2015-11-06fiscal Q3 201525670001140361-15-039902

Inspect the source

Entity
PDS Biotechnology Corp / CIK 0001472091
Captured
2026-09-20T09:07:40.584Z
SEC response SHA-256
69e1cee7a201b49964a3008a5c2ec76eaaf5723c75824c2caf8a2c52d86edef2

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001472091.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))